I must have had about 5 readers email me today about the fascinating research coming out of Yokohama National University in Japan. Professor Junji Fukuda lead the efforts to successfully prepare “hair follicle germs” at large scale simultaneously. Essentially, the researchers prepared a cellular formulation with the right culturing materials to promote successful growth and development of tiny “hair follicle starter kits.” Source article here.
Finasteride (brand name Propecia) is the closest to a hair loss cure pill that scientists have discovered to date. This is a DHT hair loss cure. DHT is made when 5 alpha reductase converts testosterone, and Propecia has been found to be an effective inhibitor of DHT by preventing this process from happening. It works internally, at the root of the cause. Therefore, DHT sensitive hair follicles in the front and top of the scalp don’t have to fight off nearly as much DHT.
Category: Alopecia Areata, Alopecia Pipeline, Hair Care Products, Hair Growth Pipeline Tags: Alopecia News, Autoimmune Disease Hair Growth, Carboxytherapy For Alopecia, Cures For Hair Loss, Cures For Hair Loss Coming Soon, Cynata Therapeutics, Deion Sanders Hair, Deion Sanders Hair Transplant Results, Gray Hair Cure, Grey Hair Cure, Hair Growth Cosmetic, Hair Loss Cure, Hair Loss News, Hair Stem Cell Cosmetic, JW Pharma Wnt Hair Growth, Organ Technologies Hair Cloning, PTD-DBM Hair Growth, Sandalore, Switch Biotech Hair Growth, WAY-316606 Hair Growth, Yonsei University Hair Research
Harklinikken does not advertise, but the 25-year-old multinational company is beginning an aggressive expansion into the $3.6 billion hair-loss market in the United States, meaning you’re likely to hear a lot more about it. A New York clinic opened in June inside the Core Club in Midtown (you don’t need to be a member to get an appointment); and in August, Harklinikken consultations became available at some 70 Women’s Care Florida obstetrics and gynecology clinics. (Roughly 75 percent of the company’s 50,000 active users are female.)
“It all started with a particular drug, Cyclosporine A, which is an immunosuppressant,” Hawkshaw explains. “It’s typically given to transplant patients to stop them rejecting new organs post-surgery and it’s been observed that it enhances hair growth. But the thing is, you don’t really want to give this to patients normally because you don’t want to suppress their immune system. So, I used that drug to treat human hair follicles in the lab to try and identify how it actually worked.”